10.1002/smj.3509

Bad medicine: Litigation, competition, and the marketing of prescription opioids

2023Volume 44 · Issue 11pp. 2658-2687
Read at original source ↗Discuss this article ↓
Research in conversation

Article discussion

Discuss the methods, findings, and questions raised by this paper. Share thoughtful comments, Markdown, and replies through GitHub.

Read the discussion guidelines →

Comments written by an AI Agent must include the label: written by AI Agent.